###begin article-title 0
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Alternative Splicing of TCF7L2 Gene in Omental and Subcutaneous Adipose Tissue and Risk of Type 2 Diabetes
###end article-title 0
###begin p 1
Conceived and designed the experiments: LPO LMK EES FSC. Performed the experiments: LPO. Analyzed the data: LPO EES. Contributed reagents/materials/analysis tools: LMK EES. Wrote the paper: LPO EES FSC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 340 346 340 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 350 355 <span type="species:ncbi:9606">human</span>
Single nucleotide polymorphisms (SNPs) rs7903146 and rs12255372 located within TCF7L2 gene have been identified as the strongest common genetic risk factors for development of type 2 diabetes (T2D). We hypothesized that these genetic variants might increase the risk of T2D through regulation of alternative splicing or expression level of TCF7L2 in human adipose tissue.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 251 257 251 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 530 536 530 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 650 652 650 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;9</sup>
###xml 679 681 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;6</sup>
###xml 732 734 732 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 758 760 758 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 787 789 787 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 886 892 886 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 992 998 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Expression of 13 assays detecting alternatively spliced forms of TCF7L2 was measured by quantitative reverse-transcriptase PCR (qRT-PCR) in paired biopsies of omental and subcutaneous adipose tissue from 159 obese individuals (BMI 54.6+/-12.2 kg/m2). TCF7L2 expression in both types of adipose tissue was not associated with SNPs rs7903146 and rs12255372, T2D status and blood levels of glucose or glycosylated hemoglobin (HbA1c). Expression of assays "ex12-13", "ex12-14" and "ex13-13a" detecting C-terminal alternative exons of TCF7L2 was higher in subcutaneous compared to omental adipose tissue by 1.46 fold (p = 6.5x10-15), 1.41 fold (p = 1.4x10-9) and 1.26 fold (p = 4.7x10-6) in the control group and by 1.86 fold (p = 1.7x10-4), 1.77 fold (p = 7.3x10-4) and 1.58 fold (p = 6.1x10-4) in the T2D group. A pathway enrichment analysis on transcripts significantly co-expressed with TCF7L2 in a microarray set combined with individual expression assays, suggested tissue-specific roles of TCF7L2 splicing forms in regulation of transcription, signal transduction and cell adhesion.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Expression of TCF7L2 alternatively spliced forms may have different functional roles in omental and subcutaneous adipose tissue but is not associated with SNPs rs7903146 and rs12255372 or T2D status.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 210 213 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Grant1">[1]</xref>
###xml 215 218 215 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Scott1">[2]</xref>
###xml 220 223 220 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Saxena1">[3]</xref>
###xml 225 228 225 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Groves1">[4]</xref>
###xml 230 236 230 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 351 354 348 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Reya1">[5]</xref>
###xml 464 470 461 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 479 482 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYC</italic>
###xml 482 485 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-He1">[6]</xref>
###xml 487 490 484 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Muncan1">[7]</xref>
###xml 495 500 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 513 516 510 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Tetsu1">[8]</xref>
###xml 917 920 914 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Merrill1">[9]</xref>
###xml 1048 1054 1045 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1077 1081 1074 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Ross1">[10]</xref>
###xml 1236 1240 1233 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Miranda1">[11]</xref>
###xml 1359 1365 1356 1362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1422 1426 1419 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Florez1">[12]</xref>
###xml 1428 1432 1425 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Cauchi1">[13]</xref>
###xml 1434 1438 1431 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Cauchi2">[14]</xref>
###xml 1440 1444 1437 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Cauchi3">[15]</xref>
###xml 1475 1481 1472 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1277 1285 <span type="species:ncbi:9606">patients</span>
Common intronic single nucleotide polymorphisms (SNPs) within the transcription factor 7 - like 2 gene (TCF7L2) have been identified as genetic factors that significantly increase risk of type 2 diabetes (T2D) [1], [2], [3], [4]. TCF7L2 belongs to a family of TCF/LEF transcription factors that interact with beta-catenin and regulate the WNT pathway [5]. Activation of the WNT pathway leads to increased cell proliferation due to effects of downstream targets of TCF7L2 such as MYC[6], [7] and CCND1 (Cyclin D1) [8]. A complex interplay of activation and repression of the WNT pathway, orchestrated by different protein isoforms of TCF/LEF transcription factors, is required for tissue-specific differentiation of stem cells. For example, differentiation of skin stem cells into either hair follicle or sebum-producing cells is regulated by expression of alternatively spliced forms of the LEF1 transcription factor [9]. Similarly, an active WNT pathway is required for myogenesis, while inactivation of the pathway by a dominant-negative form of TCF7L2 promotes adipogenesis [10]. Increased adiposity, as measured by body mass index (BMI), is a strong risk factor for development of insulin resistance, T2D and cardiovascular disease [11]. Several studies have reported that patients carrying risk alleles of the associated SNPs rs7903146 and rs12255372 of TCF7L2 have lower BMI compared to carriers of non-risk alleles [12], [13], [14], [15]. Potentially, risk alleles of TCF7L2 might increase risk of T2D even in lean individuals, or affect diabetes and adiposity through independent mechanisms.
###end p 9
###begin p 10
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Zhang1">[16]</xref>
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Graham1">[17]</xref>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 190 196 190 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Cauchi1">[13]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Elbein1">[18]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Elbein1">[18]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Elbein1">[18]</xref>
###xml 301 305 301 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Lyssenko1">[19]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Osmark1">[20]</xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Cauchi1">[13]</xref>
###xml 616 622 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 656 660 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-ProkuninaOlsson1">[21]</xref>
###xml 757 763 757 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-ProkuninaOlsson1">[21]</xref>
###xml 643 648 <span type="species:ncbi:9606">human</span>
Non-coding genetic variants can affect mRNA expression and splicing [16], [17]. Several studies attempted to correlate genotypes of T2D-associated variants of TCF7L2 with mRNA expression of TCF7L2 in adipose tissue [13], [18] skeletal muscle [18], lymphoblastoid cell lines [18] and pancreatic islets [19], [20], but no consistent associations have been reported. One study detected a significant decrease in TCF7L2 expression in obese individuals with T2D compared to obese controls, but this study was based only on six samples [13]. We previously catalogued and evaluated expression of multiple splicing forms of TCF7L2 in several types of human tissue [21]. We observed tentative association between expression of several assays for C-terminal exons of TCF7L2 and genotypes of SNPs rs7903146 and rs12255372 in pancreatic islets but not in a small set of samples of subcutaneous adipose tissue [21].
###end p 10
###begin p 11
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 499 505 499 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Here, we used 13 assays detecting all known splicing forms of TCF7L2 to evaluate gene expression in paired biopsies of subcutaneous and omental adipose tissue from 159 obese individuals. We evaluated the association between expression of these assays and genotypes of T2D-associated variants rs7903146 and rs12255372, T2D status, type of adipose tissue, BMI (37.6-89.6 kg/m2) and blood levels of glucose and glycosylated hemoglobin (HbA1c). We show that expression of alternatively spliced forms of TCF7L2 may have different functional roles in omental and subcutaneous adipose tissue but is not associated with SNPs rs7903146 and rs12255372 or T2D status.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Characteristics of the T2D and control groups
###end title 13
###begin p 14
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Grant1">[1]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Scott1">[2]</xref>
###xml 174 177 174 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Saxena1">[3]</xref>
###xml 179 185 179 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g001">Fig. 1</xref>
###xml 449 456 449 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t001">Table 1</xref>
###xml 492 495 492 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Grant1">[1]</xref>
###xml 497 500 497 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Scott1">[2]</xref>
###xml 502 505 502 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Saxena1">[3]</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-httphapmap.org1">[22]</xref>
###xml 641 642 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 986 993 986 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t001">Table 1</xref>
SNPs rs7903146 and rs12255372 are located in introns 3 and 4 of TCF7L2 gene within the associated linkage disequilibrium (LD) block and 50 kb apart from each other [1], [2], [3] (Fig. 1). In our set of 159 Caucasian individuals, the frequencies of risk alleles of both SNPs were higher in the T2D group (n = 16) than in the control group (n = 143), 0.41 in T2D vs. 0.26 in controls for rs7903146 and 0.38 in T2D vs. 0.25 in controls for rs12255372 (Table 1). Similarly to other European sets [1], [2], [3] and to the European set (CEU) of the HapMap [22], these two SNPs were in high linkage disequilibrium (LD) with each other (D' = 0.88, r2 = 0.73). Samples in the T2D and control groups were matched by age, gender and BMI by design but several T2D-related traits were significantly different between these groups: levels of blood glucose, HbA1c and homeostasis model of insulin resistance (Homa-IR) were increased, while the level of HDL cholesterol was decreased in the T2D group (Table 1).
###end p 14
###begin title 15
###xml 13 19 13 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Structure of TCF7L2 gene and location of expression assays.
###end title 15
###begin p 16
###xml 365 371 364 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
The scheme shows constitutive exons (black rectangles), alternative exons (white rectangles); linkage disequilibrium (LD) block with associated SNPs rs7903146 and rs12255372; protein domains: ss-catenin-interacting domain, DNA-binding HMG domain and C-terminal Binding Protein (CtBP)-binding domain; expression assays for detection of alternative splicing forms of TCF7L2 are indicated by connected arrows: assays TSS1, TSS2 and TSS3 target transcripts produced from alternative transcription start sites while other assays target alternatively spliced forms with different combinations of exons, * - expression of assay "ex13-13b" was tested but not detected in adipose tissue.
###end p 16
###begin title 17
Characteristics of the T2D and control groups.
###end title 17
###begin p 18
Two-sided T-test or Chi-square test (for allele frequencies) not adjusted for covariates and multiple tests.
###end p 18
###begin title 19
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Test for association between TCF7L2 expression and genotypes of rs7903146 and rs12255372, T2D status and blood levels of glucose and HbA1c
###end title 19
###begin p 20
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t002">Table 2</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t003">3</xref>
###xml 409 415 409 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g001">Fig. 1</xref>
###xml 463 467 463 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-ProkuninaOlsson1">[21]</xref>
###xml 439 444 <span type="species:ncbi:9606">human</span>
Levels of expression of 13 TCF7L2 assays in both types of adipose tissue were adjusted for age, sex, BMI and blood levels of glucose and HbA1c. Expression of these assays in each individual tissue and the ratio of subcutaneous: omental expression was similar in the control and T2D groups and in carriers of different genotypes of SNPs rs7903146 and rs1225532 (Table 2 and 3). Expression of assay "ex13-13b" (Fig. 1) previously studied in human pancreatic islets [21] was tested but not detected in adipose tissue (data not shown). Based on the number of samples and the observed standard deviation in expression of each assay, we had 80% power and 95% confidence to detect a >1.2-fold difference in expression between groups with risk and non-risk alleles for each SNP and between the T2D and control groups.
###end p 20
###begin title 21
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
Expression of TCF7L2 in omental and subcutaneous adipose tissues: comparison between T2D and control groups, 119 controls, 16 T2D patients.
###end title 21
###begin p 22
SA-subcutaneous adipose, OA- omental adipose.
###end p 22
###begin p 23
in paired samples of subcutaneous and omental adipose tissue.
###end p 23
###begin p 24
p-values for univariate analysis, adjusted for age, sex, BMI and blood levels of glucose and HbA1c but not adjusted for multiple tests.
###end p 24
###begin p 25
increase (+) or decrease (-) in expression in T2D group compared to controls.
###end p 25
###begin title 26
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Effect of presence 0, 1 or 2 risk alleles of TCF7L2 SNPs on expression of TCF7L2 in paired omental and subcutaneous adipose tissue samples, n = 134.
###end title 26
###begin p 27
SA-subcutaneous adipose, OA- omental adipose.
###end p 27
###begin p 28
ratio subcutaneous:omental expression in paired samples.
###end p 28
###begin p 29
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
p-value for linear regression model with 0, 1 or 2 risk alleles of TCF7L2 SNPs adjusted for age, sex, BMI, T2D status and blood levels of glucose and HbA1c but not adjusted for multiple tests.
###end p 29
###begin title 30
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Difference in TCF7L2 expression between omental and subcutaneous adipose tissues
###end title 30
###begin p 31
###xml 251 258 251 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t004">Table 4</xref>
###xml 446 453 446 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t004">Table 4</xref>
###xml 612 618 612 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 675 678 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 680 685 680 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 885 893 885 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g002">Figure 2</xref>
###xml 1253 1259 1253 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g002">Fig. 2</xref>
Expression of several assays was higher in subcutaneous compared to omental adipose tissue both in the control and T2D groups: 1.46 and 1.86-fold for assay "ex12-13", 1.41 and 1.77-fold for assay "ex12-14" and 1.26 and 1.58-fold for assay "ex13-13a" (Table 4). Only expression of alternative exon 3a (assay "ex3a-4") was decreased in subcutaneous compared to adipose tissue (0.81 fold) in the control group, but not in the T2D group (0.91 fold) (Table 4). The results for assays "ex12-13", "13-13a" and "12-14" will remain significant even after adjustment for multiple tests. Different ways of normalization of TCF7L2 expression (by expression levels of endogenous controls B2M, GAPDH or both genes together) did not significantly affect the conclusions (data not shown). The assays "ex12-13", "13-13a" and "12-14" detect two distinct splicing forms that include alternative exon 12 (Figure 2). The first form (GenBank FJ010174) includes C-terminal exons 11-12-13-13a and encodes a protein with a short reading frame terminated by an alternative stop codon within exon 13a. The second form (GenBank FJ010170) includes exons 11-12-14 and encodes a protein with a medium reading frame terminated by an alternative stop codon in the beginning of exon 14 (Fig. 2).
###end p 31
###begin title 32
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Alternative splicing forms of TCF7L2 with increased expression in subcutaneous compared to omental adipose.
###end title 32
###begin p 33
###xml 811 817 811 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
A. Constitutive exons 11 and 14 are marked as black rectangles, alternative exons 12, 13, 13a, 13b are marked as white rectangles, black triangles above exons indicate location of alternative stop codons that define protein reading frames: short (S), medium (M) or long (L); B. Alternative splicing form with exons 11-12-13-13a (GenBank FJ010174) has an alternative stop codon within exon 13a and encodes a protein with short reading frame; C. Alternative splicing form with exons 11-12-14 (GenBank FJ010170) has an alternative stop codon in the beginning of exon 14 and encodes a protein with medium reading frame. Positions of expression assays "ex12-13", "ex13-13a" and "12-14" used in this study are indicated above corresponding exons. Assays "ex12-13", "ex13-13a" and "12-14" detect all splicing forms of TCF7L2 that include alternative exon 12.
###end p 33
###begin title 34
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Expression of TCF7L2 in omental and subcutaneous adipose tissue in controls (n = 143) and T2D (n = 16) groups.
###end title 34
###begin p 35
SA-subcutaneous adipose, OA- omental adipose.
###end p 35
###begin p 36
- Two-sided T-test, p-values are not adjusted for multiple tests; expression in omental adipose is taken as 1.0 for each assay.
###end p 36
###begin title 37
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Pathway enrichment analysis of TCF7L2 expression
###end title 37
###begin p 38
###xml 37 43 37 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 223 227 223 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Zhong1">[23]</xref>
###xml 421 427 421 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 618 624 618 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1457 1463 1457 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1703 1710 1703 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t005">Table 5</xref>
###xml 1965 1972 1965 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007231-t005">Table 5</xref>
###xml 2045 2051 2045 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 2101 2110 2101 2110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007231.s002">Tables S2</xref>
###xml 2112 2114 2112 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007231.s003">S3</xref>
###xml 2116 2118 2116 2118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007231.s004">S4</xref>
###xml 2120 2122 2120 2122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007231.s005">S5</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
To better understand the function of TCF7L2 in human adipose tissue we searched for transcripts that positively or negatively correlated with expression of TCF7L2. We combined global expression data measured by microarrays [23] with data for individual expression assays "ex7-8", "ex3a-4", "ex12-13" and "ex13-13a", generated in the same set of 159 samples of omental and subcutaneous adipose tissue. On the microarrays, TCF7L2 was represented by 2 probes located within the 3' untranslated region (UTR) of RefSeq transcript NM_030756. The microarray probes and the assay "ex7-8" detect a mix of all splicing forms of TCF7L2, while the assays "ex12-13", "ex13-13a" and "ex3a-4" detect distinct splicing forms that showed difference in expression between the two types of adipose tissue. There was a significant correlation between the microarray and TaqMan expression data in omental adipose tissue: r2 = 0.51 for assay "ex7-8", r2 = 0.49 for assay "ex13-13a", r2 = 0.42 for assay "ex12-13" and r2 = 0.31 for "ex3a-4" but in subcutaneous adipose tissue the correlation for the same assays was not significant (r2<0.25). Using the joint expression set (microarrays and TaqMan data), we identified sets of transcripts that correlated with expression of these assays at a cutoff of r2>+/-0.25, corresponding to False Discovery Rate (FDR) p<0.0015, and analyzed each set of transcripts for enrichment of Gene Ontology categories (GO). In omental adipose tissue TCF7L2 expression positively correlated with activation of transcription through KRAB box Zn finger transcription factors but negatively correlated with protein biosynthesis, signal transduction, oxidative phosphorylation and electron transport (Table 5). In subcutaneous adipose tissue the strongest positive correlation was between expression of assay "ex13-13a" and the cadherin signaling pathway and cell adhesion, while negative correlation was detected with protein biosynthesis and receptor function (Table 5). Full list of transcripts with positive and negative correlations with TCF7L2 assays "ex12-13" and "ex13-13a" are presented in Tables S2, S3, S4, S5.
###end p 38
###begin title 39
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
Panther Classification System analysis of TCF7L2 expression in adipose tissue.
###end title 39
###begin p 40
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 113 119 113 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
OA - omental adipose; SA - subcutaneous adipose; P-positive correlation with TCF7L2, N-negative correlation with TCF7L2.
###end p 40
###begin p 41
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
transcripts with positive or negative correlation (r2>+/-0.25, p<0.0015) with expression of TCF7L2 assays.
###end p 41
###begin p 42
number of transcripts in each GO category among 20,316 annotated transcripts on the array.
###end p 42
###begin p 43
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
number of transcripts with significant correlation with TCF7L2 expression in each GO category.
###end p 43
###begin p 44
expected number of transcripts in each GO category based on the frequencies on the array.
###end p 44
###begin p 45
direction (enrichment or deficit) in each GO category.
###end p 45
###begin p 46
p-value for differences between observed and expected number of transcripts in each GO category Bonferroni-adjusted for number of GO categories.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 65 71 65 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 677 683 677 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 807 811 807 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Wegner1">[24]</xref>
Our study provides a detailed analysis of expression of multiple TCF7L2 splicing forms in paired biopsies of omental and subcutaneous adipose tissue from a large set of obese individuals. The first goal of this study was to evaluate the association between the expression of TCF7L2 splicing forms and T2D-associated SNPs rs7903146 and rs12255372, T2D status or blood levels of glucose or HbA1c. Despite 80% of power to detect >1.2 fold differences in expression between different groups, we did not observe any significant association between these factors. Our results are similar to a recently published data on 235 samples of subcutaneous adipose tissue where expression of TCF7L2 (measured by one assay corresponding to our "ex7-8" assay) was not affected by T2D status, sex, and genotypes of rs7903146 [24].
###end p 48
###begin p 49
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 503 509 503 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Kovacs1">[25]</xref>
###xml 778 782 778 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Kovacs1">[25]</xref>
###xml 1426 1430 1426 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Kovacs1">[25]</xref>
The second goal of this study was to compare the expression of TCF7L2 splicing forms in two types of adipose tissue. We observed that expression of assays "ex12-13", "ex12-14" and "ex13-13a" was higher in subcutaneous compared to omental tissue and this difference could not be explained by genotypes of the T2D-associated SNPs, sex, BMI and blood levels of glucose and HbA1c. These findings were similar to the results of a study that did not detect association between expression of assay "ex9-10" of TCF7L2 and genotypes of rs7903146, rs12255372, age, sex and BMI in paired biopsies of adipose tissue from 49 individuals [25]. However, the expression of this assay was 4.8-fold higher in subcutaneous compared to omental tissue in controls and 6-fold higher in the T2D group [25]. The effects observed in our study were weaker, 1.46-fold in the control group and 1.86-fold in the T2D group and the effect was not detectable for assay "ex7-8" that measures the same splicing forms as assay "ex9-10". This could potentially be attributed to the difference in sample size (159 samples in our study and 49 samples in Kovacs et al.), use of different custom-designed expression assays and reference genes (one reference gene at Kovacs et al. and two reference genes in our study). Additionally, individuals in our study were more obese (BMI 54.6+/-12.2) compared to less obese individuals in Kovacs et al (BMI 29.7+/-0.8 kg/m2) [25].
###end p 49
###begin p 50
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 267 273 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 303 309 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 785 791 785 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 957 963 957 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1009 1013 1009 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-ProkuninaOlsson1">[21]</xref>
###xml 1033 1041 1033 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g002">Figure 2</xref>
###xml 1276 1280 1276 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Osmark1">[20]</xref>
###xml 1281 1285 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-httphapmap.org1">[22]</xref>
###xml 1593 1599 1593 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1853 1861 1853 1861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007231-g002">Figure 2</xref>
###xml 2042 2046 2042 2046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Fang1">[26]</xref>
TCF7L2 is a ubiquitously expressed transcription factor that mediates signals of the WNT pathway. The function of TCF7L2 and, particularly, in different types of adipose tissue is not clear. A pathway enrichment analysis on transcripts significantly coexpressed with TCF7L2 showed that the main role of TCF7L2 in omental adipose tissue is associated with activation of transcription and inhibition of protein biosynthesis and signal transduction. In contrast, in subcutaneous adipose tissue we did not observe any evidence for correlation with activation of transcription, but with increased cell adhesion through cadherin protein family (for assay "ex13-13a"). Adipose consists of several types of cells such as adipocytes, endothelial cells, macrophages that can differently express TCF7L2. For example, assays "ex12-13" and "13-13a" specifically detect a unique splicing form that includes exons 12-13-13a, expressed in multiple tissues and is the major TCF7L2 splicing form in peripheral blood monocytes ([21], GenBank FJ010174, Figure 2). Adhesion of monocytes to endothelial lining of capillaries, infiltration into adipose tissue and differentiation into macrophages contributes to low-grade chronic inflammation in adipose tissue and development of insulin resistance [20]-[22]. Therefore, increased expression of assays "ex12-13" and "ex13-13a" in subcutaneous adipose tissue and co-expression with genes involved in cell adhesion might indicate increased monocytes influx into subcutaneous adipose tissue or other functional differences between these two tissue types. All assays of TCF7L2 with significantly increased expression in subcutaneous compared to omental adipose ("ex12-13", "ex13-13a" and "ex12-14") detect splicing forms that encode truncated TCF7L2 protein with short or medium reading frames and include an alternative exon 12 (Figure 2). The truncated protein isoforms of TCF7L2 lack binding sites for the CTBP protein are not post-translationally regulated and may provide alternative regulation of the WNT pathway [26].
###end p 50
###begin p 51
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 192 198 192 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
In conclusion, we did not observe association between expression of TCF7L2 splicing forms, T2D status and genotypes of T2D-associated SNPs rs7903146 and rs12255372. Differential expression of TCF7L2 splicing forms with alternative exon 12 encoding for truncated protein isoforms of TCF7L2 in omental and subcutaneous adipose tissues deserves future studies.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Ethics Statement
###end title 53
###begin p 54
The study on anonymized samples was approved by the Internal Review Board (IRB) of Massachusetts General Hospital, protocol #2001-P-001942/22 and exempted from IRB approval at the NHGRI/NIH.
###end p 54
###begin title 55
Tissue samples
###end title 55
###begin p 56
###xml 170 174 170 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Zhong1">[23]</xref>
###xml 87 95 <span type="species:ncbi:9606">patients</span>
###xml 721 729 <span type="species:ncbi:9606">patients</span>
Paired samples of omental and subcutaneous adipose tissue were obtained from bariatric patients that underwent weight-reduction surgery and signed informed consent forms [23]. Following traits were available for all or subsets of samples: age, gender, BMI, white blood cells counts (WBC), fasting levels of glucose, insulin, total cholesterol, HDL and LDL cholesterol, triglycerides, homeostasis model of insulin resistance (Homa-IR) and glycosylated hemoglobin (HbA1c). The T2D status was assigned to individuals with fasting blood glucose higher than 140 mg/dl (7.8 mmol/L). Total RNA from flash-frozen adipose samples was extracted using Trizol reagent (Invitrogen) and DNA was isolated from liver samples of the same patients with DNeasy kit (Qiagen).
###end p 56
###begin title 57
Genotyping
###end title 57
###begin p 58
Genotyping was performed with pre-developed TaqMan allelic discrimination assays for rs7903146 and rs12255372 (Applied Biosystems). The genotyping success was above 99% and only samples genotyped for both markers were used.
###end p 58
###begin title 59
Quantitative reverse-transcriptase PCR (qRT-PCR) expression studies
###end title 59
###begin p 60
###xml 139 143 139 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Zhong1">[23]</xref>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-ProkuninaOlsson1">[21]</xref>
###xml 365 373 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007231.s001">Table S1</xref>
cDNA was prepared from total RNA of selected samples of omental and subcutaneous adipose tissue used for the microarray expression studies [23]. For each sample, 100 ng of total RNA was convereted to cDNA with SuperScript III reverse transcriptase and random hexamers (Invitrogen). Expression assays for TCF7L2 were custom designed for each splicing form ([21] and Table S1). Primers for SYBR Green assays were purchased from Integrated DNA Technologies and TaqMan assays were manufactured on demand by Applied Biosystems. qRT-PCR was performed in a 10 ul reaction volume in 384 well plates with Power SYBR Green master mix (Applied Biosystems) or Expression Master Mix for TaqMan assays (Applied Biosystems) on the Sequence Detection System 7900 (Applied Biosystems). Each expression assay was run in technical duplicates and the average values for each sample were normalized to a geometric mean of mRNA levels of reference genes beta 2 microglobulin (B2M, assay Hs00187842_m1, Applied Biosystems) and Glyceraldehyde 3-phosphate dehydrogenase (GAPDH, assay 4333764F, Applied Biosystems) run in separate reactions from the same cDNA preparations.
###end p 60
###begin title 61
Statistical analyses
###end title 61
###begin p 62
###xml 503 509 503 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
qRT-PCR expression was measured in Ct values (PCR cycle at which expression was detected). For each sample and assay, the average of technical replicates was first normalized to a geometric mean values of reference genes, B2M and GAPDH according to the formula: Ct(geometric) = (Ct(B2M)+Ct(GAPDH))/2. Relative expression of each assay was calculated as: dCt = Ct(geometric)-Ct(assay). For each assay, the dCt values were first tested for normality of distribution. The association between expression of TCF7L2 assays and the counts of risk alleles (0, 1, 2) of the T2D-associated SNPs rs7903145 and rs12255372 was tested with univariate linear regression model with adjustment for covariates (age, sex, and log-transformed values of BMI and blood levels of glucose and HbA1c). The analyses were performed with SPSS 16.0 (SPSS Inc.). Microarray expression was analyzed with R statistical programming package. Power analysis was performed with StatMate 2.0 (GraphPad) and was based on standard deviations in expression of each of assays, number of samples with 0 or 1 and 2 risk alleles at each SNP and 80% power to detect the difference with 5% of type I error.
###end p 62
###begin title 63
Joint analysis of the microarray and TaqMan data, pathway enrichment analysis
###end title 63
###begin p 64
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Zhong1">[23]</xref>
###xml 491 497 491 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 605 611 605 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 744 750 744 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 846 849 846 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 928 933 928 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 938 941 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 1032 1035 1032 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M</italic>
###xml 1040 1045 1040 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 1264 1273 1264 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH/B2M</italic>
###xml 1306 1315 1306 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH/B2M</italic>
###xml 1371 1380 1371 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B2M/GAPDH</italic>
###xml 1419 1425 1419 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 1778 1784 1778 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 2244 2248 2244 2248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Thomas1">[27]</xref>
###xml 2445 2451 2445 2451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF7L2</italic>
###xml 2626 2630 2626 2630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007231-Thomas1">[27]</xref>
The microarray data for 159 paired samples of omental and subcutaneous adipose tissue was a part of a previously described study [23]. The microarray data was available to all authors of the article and is available upon request. Each of the RNA samples was profiled with custom-designed microarrays that included 39,280 oligonucleotide probes representing 34,266 known and predicted genes (Agilent Technologies, Palo Alto, CA). We used assays "ex3a-4", "ex7-8", ex"12-13" and "ex13-13a" of TCF7L2 for joint analysis of expression. Expression of B2M and GAPDH was used as an endogenous control for TaqMan TCF7L2 expression. However, when we combined the TaqMan and microarray data, we observed that the sets of transcripts that correlated with TCF7L2 expression significantly overlapped with the set of transcripts that correlated with GAPDH and B2M expression. To remove this biologically relevant variation component from the GAPDH and B2M expression, we identified a set of transcripts that correlated with the geometric mean of B2M and GAPDH expression at a 5% FDR (false-discovery rate). We then performed Principal Component Analysis on this set of transcripts to identify those factors (eigenvectors) that explained greater than 90% of the variation in the GAPDH/B2M geometric mean and adjusted the GAPDH/B2M expression by each of these eigenvectors. The adjusted B2M/GAPDH expression was then used to normalize TCF7L2 expression using standard linear regression methods. For co-expression analysis, the normalized expression values for all transcripts were adjusted for age and sex and the residuals were computed using the rlm function from the R statistical package (M-estimation with Tukey's bisquare weights). The Spearman correlation coefficients for expression of TCF7L2 and all other transcripts were calculated. The FDR for these correlations was calculated by performing 1000 permutations of sample IDs while preserving the correlation structure among the gene expression values. The threshold for Spearman coefficient was set up at r = +/-0.25, corresponding to FDR<1% (p-value<0.0005). The pathway enrichment analysis on sets of transcripts with significant correlations was performed using the Panther Classification System [27]. For each GO category, we compared expected and observed frequencies between a set of 20,316 annotated transcripts presented on the array and the sets of transcripts significantly correlated with TCF7L2 expression. The p-value for significance of enrichment in each group was adjusted for the number of GO categories using Bonferroni method implemented in the Panther analysis [27].
###end p 64
###begin title 65
Supporting Information
###end title 65
###begin p 66
Primers and probes for expression assays.
###end p 66
###begin p 67
(0.04 MB RTF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
List of significant correlations between TCF7L2 assay.
###end p 69
###begin p 70
(0.05 MB XLS)
###end p 70
###begin p 71
Click here for additional data file.
###end p 71
###begin p 72
List of significant correlations between TCF7L2 assay.
###end p 72
###begin p 73
(0.27 MB XLS)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
List of significant correlations between TCF7L2 assay.
###end p 75
###begin p 76
(0.17 MB XLS)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
List of significant correlations between TCF7L2 assay.
###end p 78
###begin p 79
(0.11 MB XLS)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 23 31 <span type="species:ncbi:9606">patients</span>
We are thankful to all patients participated in this study, Victor Castro at MGH for assistance in sample collection, Christine Suver and the Rosetta Gene Expression Laboratory for sample preparation.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes.
###end article-title 83
###begin article-title 84
Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.
###end article-title 84
###begin article-title 85
Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals.
###end article-title 85
###begin article-title 86
Association analysis of 6,736 U.K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk.
###end article-title 86
###begin article-title 87
Wnt signalling in stem cells and cancer.
###end article-title 87
###begin article-title 88
Identification of c-MYC as a target of the APC pathway.
###end article-title 88
###begin article-title 89
Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc.
###end article-title 89
###begin article-title 90
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
###end article-title 90
###begin article-title 91
Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin.
###end article-title 91
###begin article-title 92
Inhibition of adipogenesis by Wnt signaling.
###end article-title 92
###begin article-title 93
Metabolic syndrome: definition, pathophysiology, and mechanisms.
###end article-title 93
###begin article-title 94
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
###end article-title 94
###begin article-title 95
###xml 82 87 <span type="species:ncbi:9606">human</span>
Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
###end article-title 95
###begin article-title 96
TCF7L2 Variation Predicts Hyperglycemia Incidence in a French General Population: The Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) Study.
###end article-title 96
###begin article-title 97
Effects of TCF7L2 polymorphisms on obesity in European populations.
###end article-title 97
###begin article-title 98
###xml 96 101 <span type="species:ncbi:9606">human</span>
Identification of common genetic variants that account for transcript isoform variation between human populations.
###end article-title 98
###begin article-title 99
A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
###end article-title 99
###begin article-title 100
###xml 118 130 <span type="species:ncbi:9606">participants</span>
Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.
###end article-title 100
###begin article-title 101
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
###end article-title 101
###begin article-title 102
###xml 46 51 <span type="species:ncbi:9606">human</span>
Unique splicing pattern of the TCF7L2 gene in human pancreatic islets.
###end article-title 102
###begin article-title 103
Tissue-specific alternative splicing of TCF7L2.
###end article-title 103
###begin article-title 104
Elucidating Networks of eSNPs Associated with Type 2 Diabetes.
###end article-title 104
###begin article-title 105
Impact of TCF7L2 rs7903146 on Insulin Secretion and Action in Young and Elderly Danish Twins.
###end article-title 105
###begin article-title 106
###xml 26 31 <span type="species:ncbi:9606">human</span>
TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
###end article-title 106
###begin article-title 107
###xml 91 101 <span type="species:ncbi:7227">Drosophila</span>
C-terminal-binding protein directly activates and represses Wnt transcriptional targets in Drosophila.
###end article-title 107
###begin article-title 108
Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools.
###end article-title 108
###begin p 109
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 109
###begin p 110
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was supported by the Intramural Research Programs of the NHGRI and NCI/NIH. One of the authors (EES) is employed by Pacific Biosciences. The company did not have a role in funding or oversight of this study, data collection and analysis, decision to publish, or preparation of the manuscript. No patent can be claimed based on this study.
###end p 110

